What AV8 Ventures does

AV8 Ventures is an early-stage venture capital firm headquartered in Palo Alto, California, that invests Seed and Series A capital into startups across four core sectors: healthcare, enterprise software, financial technology and services, and deep tech. Founded in 2018, the firm positions itself as a "full lifecycle investor" that commits early and partners with founders for the long term, providing capital alongside operational expertise and network access. Its portfolio spans approximately 16 named companies, including women's telehealth provider Alpha Medical, cancer-detection startup Delfi Diagnostics, device security firm Eclypsium, mobile observability tool Embrace.io, biotech platform Think Bioscience, healthcare workforce intelligence platform Axuall, Medicare Advantage carrier Clever Care Health Plan, community health value-based-care operator Yuvo Health, microfluidic immunotherapy platform Shennon Bio, AI-based security automation tool Cerby, manufactured-home insurer Covertree, digital SMB insurance agency Glow, cyber insurance carrier Measured Analytics and Insurance, data intelligence platform DataGalaxy, workplace safety wearable Soter Analytics, and financial crime risk scoring firm Elucidate.

The firm's core offering is direct minority equity investment rather than a software product or technology platform. Its differentiation rests on a small core investment team — Managing Director and founder George Ugras, healthcare-focused partner Ruchita Sinha, partner Brett Battles, operating partner Serpil Kuyucak Schiebel, and venture partner Shawn Kung — supplemented by an external bench of approximately ten venture advisors drawn from companies including Asana, Google, UiPath, Square, LinkedIn, Fifth Third Bank, Zest AI, Stanford, and Nvidia. AV8 markets itself through a content-driven approach, publishing sector white papers on enterprise automation, healthcare innovation, and mobility/autonomy, alongside a blog featuring founder interviews and insurtech commentary.

AV8 Ventures generates revenue through the conventional venture capital model of management fees and carried interest on its fund vehicles. Fund II, a $180 million vehicle, was launched in September 2021 with capital commitment from Allianz, one of the world's largest integrated financial services providers. The Allianz relationship functions simultaneously as an anchor LP, a source of patient capital, and a strategic differentiator that grants AV8 proximity to insurance industry expertise and distribution. The firm is privately held, has no public revenue disclosures, and operates from a single Palo Alto office with a core team of five members.

Name

AV8 Ventures

Legal name

AV8 Ventures

Website

https://av8.vc

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

AV8 Ventures is an early-stage venture capital firm based in Palo Alto that invests Seed and Series A capital in healthcare, enterprise, financial services, and deep tech startups. The firm manages a $180 million fund backed by Allianz.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Portfolio Management and Investment Advice (52394), Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Early-Stage Venture Capital (Series A/B) (FSANAAAB)

akta.pro secondary industry

Micro-VC & Angel Funds (FSANAAAI)

Keywords

• Venture capital investing
• Early stage funding
• Seed stage investments
• Healthcare venture capital
• Enterprise software investing

Headquarters

HQ city

Palo Alto

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Fund Management: VC fund management generating returns through carried interest and management fees from Fund II, a $180M fund backed by Allianz.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

AV8 Ventures is an early-stage venture capital firm that deploys Seed and Series A capital into startups operating in healthcare, enterprise software, financial technology and services, and deep tech. The firm backs founders with equity capital, operational guidance, and access to a venture advisor network, committing early and partnering for the long term. Its capital is sourced primarily through managed funds (including AV8 Fund II, a $180 million vehicle backed by Allianz).

Product overview

AV8 Ventures is a venture capital firm structured as a single unified investment platform. The firm backs early-stage start-ups focused on four key sectors: Healthcare, Enterprise, Financial Services, and Deep Tech. They typically invest at the Seed or Series A stage and commit early, partnering for the long term. The firm is backed by Allianz and manages multiple funds (including AV8 Fund II, a $180M fund). The investment offering includes capital deployment, operational expertise, network access, and venture advisor support to help founders build their companies.

Differentiator

Problem solved

Functional benefit

Products and services

• AV8 Ventures Investment Services Early-stage venture capital investment services providing Seed and Series A equity financing to founders building category-defining companies in healthcare, enterprise software, financial technology and services, and deep tech, with operational support and venture advisor network access.

Quantifiable outcome

• Backed by Allianz, one of the leading integrated financial services providers worldwide

Named customers16 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• Costanoa Ventures: Early-stage venture firm focused on enterprise software and fintech, with offices in Palo Alto. Directly comparable to AV8 for deal flow in B2B software and similar Seed/Series A stage investing approach.
• Cowboy Ventures: Palo Alto-based early-stage VC investing Seed/Series A across consumer, enterprise, and healthcare. Comparable stage, geography, and operator-friendly model to AV8's investment approach.
• Lerer Hippeau: Early-stage venture firm investing Seed/Series A in enterprise, consumer, and healthcare. Directly comparable investment stage and thematic breadth to AV8's portfolio construction.
• M13: Early-stage VC investing across consumer, enterprise, fintech, and healthcare with an operator-driven platform model. Comparable to AV8 in stage, sector focus, and emphasis on operational support.
• Eniac Ventures: Seed-stage venture firm with focus on enterprise, mobile, and healthcare. Directly comparable to AV8 for early-stage deal flow and similar check sizes at the Seed stage.
• Wing Venture Capital: Early-stage enterprise software investor with an operator-heavy team. Directly comparable to AV8's enterprise focus, similar stage, and similar operator-led investment thesis.
• Crosscut Ventures: LA-based early-stage VC investing Seed/Series A across enterprise, consumer, and fintech. Comparable to AV8 in stage and multi-sector approach, with similar check sizes.

Emerging players

• Anthemis: Fintech-focused VC with deep insurance industry expertise, partnered with multiple insurance carriers. Comparable to AV8's insurtech focus and Allianz partnership, though more narrowly sector-focused.

Broad incumbents

• Sanofi Ventures: Strategic CVC arm of Sanofi focused on healthcare/biotech. Ruchita Sinha led digital health investing here before joining AV8, providing direct competitive overlap for healthcare deal flow.
• GE Ventures: Strategic venture arm of GE that invests across enterprise, healthcare, and industrial tech. Comparable to AV8's Allianz-backed strategic investor profile, and a former employer of AV8's healthcare lead.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/av8-ventures

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments68 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AV8 Ventures